Cancer treatment in the last 6 months of life: when inaction can outperform action

A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers

Improving global breast cancer care

What will we expect from novel therapies for oesophageal and gastric malignancies?

Nelarabine in newly diagnosed paediatric T-cell malignancies

Immunotherapy trials and hyperprogressive disease

First-in-human phase 1 study of TAK-931 for solid tumours

Web-mediated follow-up via patient-reported outcomes vs. routine surveillance in lung cancer patients

The CAPTIVATE trial of ibrutinib and venetoclax as a first line treatment for CLL patients

Development of blood tests for early lung cancer

Linking Lynch Syndrome and microsatellite instability in tumours

Matching personalised therapies to patients in the IMPACT trial